Clinical Trial Update: A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating AUY922 for Gastrointestinal Stromal Tumor is referenced, with the study sponsored by the National Health Research Institutes i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• AUY922 (luminespib)

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Gastrointestinal Stromal Tumor | Phase 2 | Status: UNKNOWN